Showing 1291-1300 of 1679 results for "".
The Best Asset Protection Implementation is Not Asset Protection... Is Yours?
https://practicaldermatology.com/topics/practice-management/the-best-asset-protection-implementation-is-not-asset-protection-is-yours/21472/A review of plans that will offer protection if needed and help build wealth along the way.Keep the Insurance Profit, Reduce Taxes, Protect Assets: Own Your Own Insurance Company
https://practicaldermatology.com/topics/practice-management/keep-the-insurance-profit-reduce-taxes-protect-assets-own-your-own-insurance-company/21516/Patient Outreach: Lost to Follow-up Doesn't Have to Mean Lost
https://practicaldermatology.com/topics/practice-management/patient-outreach-lost-to-follow-up-doesnt-have-to-mean-lost/21531/Effective patient outreach improves outcomes, saves lives, and increases practice revenue.In-Review: Two New Melanoma Agents Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/in-review-two-new-melanoma-agents-approved/21534/Utilizing genetic abnormalities, new therapies are carving out new possibilities for melanoma treatment.Hensin Tsao, MD, PhD
https://practicaldermatology.com/topics/skin-cancer-photoprotection/hensin-tsao-md-phd/22978/Taking the Pulse of Device-based Aesthetics Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/taking-the-pulse-of-device-based-aesthetics-procedures/22956/With new developments in store, the evolution of devices for aesthetic procedures is creating new possibilities.From Clinic to Capitol: Tips for Building Grassroots and Legislative Support For Anti-Tanning Policies in Your State
https://practicaldermatology.com/topics/skin-cancer-photoprotection/from-clinic-to-capitol-tips-for-building-grassroots-and-legislative-support-for-anti-tanning-policies-in-your-state/22943/It's no easy task to shepherd legislation through state assemblies, but dermatologists' clinical standing can have some influence.The Logistics of Biologics
https://practicaldermatology.com/topics/psoriasis/the-logistics-of-biologics/22932/The road from prescription to administering biologic agents may not always be smooth, but these clinical and practical tips will help to expedite the process.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/